• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Upcoming dvm360 Conferences
Resources
CBD in Pets
CE Requirements by State
Contests
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
Veterinary Heroes
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Journal Scan: Methocarbamol as a CRI for pyrethroid intoxication: A look at three cases

May 1, 2014
Jennifer L. Garcia, DVM, DACVIM

A study looks at whether the use of methocarbamol as a continuous rate infusion (CRI) may decrease the risk of side effects from using multiple drugs.

Why they did it

Pyrethroid intoxication due to improper use or accidental ingestion is often seen in veterinary medicine, and symptomatic support with intermittent injections of methocarbamol to relieve muscle tremors is often required. The use of methocarbamol as a continuous rate infusion (CRI) may decrease the risk of side effects from using multiple drugs with little muscle relaxation effect. In this report, the authors describe three cases in which methocarbamol was successfully used as a CRI.

What they did

Between February 2009 and June 2010, two cats and one dog were treated for pyrethroid intoxication at two veterinary teaching hospitals. All three patients were treated with diazepam (range = 0.5 to 1 mg/kg intravenously), and two were treated with phenobarbital (range = 2 to 6 mg/kg intravenously), which did not effectively control the muscle tremors. In addition, one patient was treated with mannitol and oxygen because of suspicion of head trauma, and one patient was treated with 2.5% dextrose because of hypoglycemia at the time of presentation.

All three patients were bathed to remove residual drug from the skin and coat. After an initial positive response to an intravenous methocarbamol bolus (range = 43.5 to 89.3 mg/kg), all three patients were treated with a methocarbamol CRI.

Case #1

3-year-old 5.6-kg castrated male domestic shorthaired cat

CRI dose

• 8.8 mg/kg/hr IV

• Decreased to 4.7 mg/kg/hr at 8 hours and discontinued at 12 hours

Clinical resolution

Advertisement

The patient was discharged the same day with minimal tremors and was prescribed oral methocarbamol (45 mg/kg orally every eight hours for two days). Clinical signs had resolved at follow-up three days after discharge.

Case #2

2-year-old 4.6-kg spayed female domestic longhaired cat

CRI dose

• 11.6 mg/kg/hr IV

• CRI was tapered off the following day

Clinical resolution

Methocarbamol (54 mg/kg orally every 12 hours) was prescribed for three days at the time of discharge. No tremors were reported at follow-up several days later.

Case #3

5-year-old 8.2-kg castrated male miniature schnauzer

CRI dose

• 12.2 mg/kg/hr IV for 4 hours

• Reduced to 9.1 mg/kg/hr for 10 hours, then 3 mg/kg/hr for seven hours, and then stopped

Clinical resolution

Methocarbamol (61 mg/kg orally every eight hours for eights days—started at the same time as the 3 mg/kg/hr CRI). Discharged the following day. No tremors were reported at follow-up contact the day after discharge.

What they found

All three cases responded well to the initial intravenous bolus, and clinical signs were well-controlled when the patients were treated with the methocarbamol CRI. However, it is unclear whether resolution of clinical signs was due to methocarbamol alone.

The authors acknowledge that information regarding pharmacokinetics and pharmacodynamics of methocarbamol as a CRI in dogs and cats is lacking. The CRI dose was based on the known maximum safe dose of methocarbamol (330 mg/kg/day), and the initial boluses of methocarbamol were subtracted from this amount when calculating the CRI.

The authors note that the drug may be administered as a CRI on its own or added to crystalloid fluids. Although a small case series, the authors did not note any side effects associated with the use of methocarbamol as a CRI.

Take-home message

In patients suspected of pyrethroid intoxication that have a positive response to an initial intravenous bolus of methocarbamol, a methocarbamol CRI should be considered so that multiple drugs that can cause side effects but not produce much muscle relaxation are not needed. When and how to taper the methocarbamol CRI will depend on a patient’s response and your clinical judgment. Overall prognosis for recovery is good if prompt and aggressive treatment is instituted in conjunction with standard supportive care.

Draper WE, Bolfer L, Cottam E, et al. Methocarbamol CRI for symptomatic treatment of pyrethroid intoxication: a report of three cases. J Am Anim Hosp Assoc 2013; Epub ahead of print.

Link to article: http://www.jaaha.org/content/early/2013/03/26/JAAHA-MS-5835.abstract

Jennifer L. Garcia, DVM, DACVIM, is a veterinary internal medicine specialist at Sugarland Veterinary Specialists in Houston, Texas.

Related Content:

Clinical
ABCs of dentistry: Airway, breathing, and circulation
ABCs of dentistry: Airway, breathing, and circulation
What's new with the "Dentistry Lane" across the veterinary profession?
What's new with the "Dentistry Lane" across the veterinary profession?
Performing and calculating a PCV
Performing and calculating a PCV

Advertisement

Latest News

Partners for Health Pets and VHMA collaboration publish white paper

Vetstoria releases its Fill Rate platform

What's new with the "Dentistry Lane" across the veterinary profession?

Meet the BlackDVM Network

View More Latest News
Advertisement